Page last updated: 2024-10-24

calmidazolium and Carcinoma, Renal Cell

calmidazolium has been researched along with Carcinoma, Renal Cell in 1 studies

calmidazolium: powerful inhibitor of or red blood cell Ca++-ATPase & Ca++ transport into inside-out red blood cell vesicles; RN refers to chloride; structure in first source; an antagonist of calmodulin
calmidazolium : An imidazolium ion that is imidazolium cation substituted by a bis(4-chlorophenyl)methyl group at position 1 and a 2-[(2,4-dichlorobenzyl)oxy]-2-(2,4-dichlorophenyl)ethyl group at position 3. It acts as an antagonist of calmodulin, a calcium binding messenger protein.

Carcinoma, Renal Cell: A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hansen, AB1
Bouchelouche, PN1
Lillevang, ST1
Andersen, CB1

Other Studies

1 other study available for calmidazolium and Carcinoma, Renal Cell

ArticleYear
Interferon-gamma increases cellular calcium ion concentration and inositol 1,4,5-trisphosphate formation in human renal carcinoma cells: relation to ICAM-1 antigen expression.
    British journal of cancer, 1994, Volume: 69, Issue:2

    Topics: Antigens; Calcimycin; Calcium; Carcinoma, Renal Cell; Cell Adhesion Molecules; Cell Survival; Cultur

1994